Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$17.13 - $26.91 $272,812 - $428,568
-15,926 Reduced 99.99%
1 $0
Q4 2023

Feb 13, 2024

BUY
$21.58 - $29.5 $343,704 - $469,846
15,927 New
15,927 $430,000
Q2 2023

Aug 11, 2023

BUY
$20.94 - $38.01 $478,206 - $868,034
22,837 New
22,837 $817,000
Q4 2022

Feb 13, 2023

BUY
$25.44 - $59.78 $833,185 - $1.96 Million
32,751 Added 133.66%
57,254 $1.56 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $1.62 Million - $2.26 Million
-37,118 Reduced 60.24%
24,503 $1.35 Million
Q2 2022

Aug 12, 2022

BUY
$28.82 - $77.35 $758,945 - $2.04 Million
26,334 Added 74.63%
61,621 $2.49 Million
Q1 2022

May 13, 2022

SELL
$48.25 - $100.49 $1.4 Million - $2.91 Million
-28,953 Reduced 45.07%
35,287 $2.34 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $2.27 Million - $3.08 Million
25,605 Added 66.27%
64,240 $6.43 Million
Q3 2021

Nov 12, 2021

SELL
$98.77 - $132.17 $1.18 Million - $1.58 Million
-11,973 Reduced 23.66%
38,635 $4.83 Million
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $683,647 - $1.03 Million
6,228 Added 14.03%
50,608 $6.29 Million
Q1 2021

May 14, 2021

SELL
$127.04 - $179.1 $1.23 Million - $1.73 Million
-9,681 Reduced 17.91%
44,380 $6.78 Million
Q4 2020

Feb 12, 2021

BUY
$99.96 - $135.93 $360,455 - $490,163
3,606 Added 7.15%
54,061 $6.97 Million
Q3 2020

Nov 12, 2020

SELL
$80.32 - $111.8 $574,609 - $799,817
-7,154 Reduced 12.42%
50,455 $5.64 Million
Q2 2020

Aug 13, 2020

BUY
$60.49 - $97.5 $3.48 Million - $5.62 Million
57,609 New
57,609 $4.67 Million
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $23.4 Million - $32.5 Million
-392,765 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$62.59 - $110.3 $23.5 Million - $41.3 Million
374,813 Added 2087.86%
392,765 $25.1 Million
Q2 2019

Aug 13, 2019

SELL
$63.94 - $91.11 $4.2 Million - $5.99 Million
-65,713 Reduced 78.54%
17,952 $1.55 Million
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $2.87 Million - $8.2 Million
83,665 New
83,665 $6.17 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.